VEGF gene variability and type 1 diabetes: evidence for a protective role
Roberto Del Bo(University of Milan), Gianpaolo Zerbini(Vita-Salute San Raffaele University), Per‐Henrik Groop(University of Helsinki), Lisa Sjölind(Helsinki University Hospital), Giacomo P. Comi(University of Milan), Livio Luzi, Nereo Bresolin(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Anna Maestroni, Maija Wessman(University of Helsinki), Marina Scarlato(University of Milan), Serena Ghezzi(University of Milan), Carol Forsblom(University of Helsinki)
Cited by 36
Related Papers
The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
|Diabetes|2009|641
Cell Therapy of α-Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts
|Science|2003|620
Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney Disease
|Journal of the American Society of Nephrology|2013|578
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
|Diabetes|1999|509
Metabolic Syndrome in Type 1 Diabetes
|Diabetes Care|2005|428